
UCH-L1 Antibody (13C4) is a mouse monoclonal IgG2a antibody that detects UCH-L1 in mouse, rat, and human samples through western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and immunohistochemistry. UCH-L1, or ubiquitin C-terminal hydrolase L1, plays a crucial role in the ubiquitin-proteasome system by hydrolyzing ubiquitin adducts to release free ubiquitin, which is essential for protein degradation and cellular homeostasis. UCH-L1 is predominantly expressed in neurons and neuroendocrine cells, with significant localization in the substantia nigra, an area critically involved in motor control. The presence of UCH-L1 in Lewy bodies, which are pathological hallmarks of Parkinson′s disease, underscores its importance in neurodegenerative processes. UCH-L1 constitutes about 1-2% of total soluble brain protein, highlighting its abundance and potential as a biomarker for neurodegenerative disorders. The gene encoding UCH-L1 is located on human chromosome 4p13, and its structural similarity to UCH-L3, which shares 54% identity, suggests a conserved function within the ubiquitin pathway. Anti-UCH-L1 antibody (13C4) is an invaluable tool for researchers investigating the role of ubiquitin-related processes in neurobiology and disease.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
UCH-L1 Antibody (13C4) | sc-58594 | 200 µg/ml | $322.00 | |||
UCH-L1 Antibody (13C4): m-IgGκ BP-HRP Bundle | sc-521055 | 200 µg Ab, 40 µg BP | $361.00 |